Systematic Reveiws
Copyright ©The Author(s) 2017.
World J Hepatol. May 18, 2017; 9(14): 677-688
Published online May 18, 2017. doi: 10.4254/wjh.v9.i14.677
Table 8 Overview of sustained viral response in the 8 studies providing information on baseline inducible protein-10’s, and hepatitis C virus-RNA levels 24 wk after end-of- treatment
Ref.Patients (n)IP-10 measurement methodGenotype (n)Baseline IP-10 concentration, grouped by sustained virological response (pg/mL)
Overall SVR
SVRNon-SVRP-valueSVRNon-SVR
Apolinario et al[9]63ELISA (OptEIA, Pharmingen, San Diego, CA, United States)1 (43)245 (± 154)381 (± 138)P < 0.05 (mean ± SD)3627
Diago et al[7]137ELISA (Human immunoassay kit; BioSource Europe SA, Nivelles, Belgium1 (103)347 (± 197.4)500.6 (± 311.2)P < 0.01 (mean ± SD)792582
1 (103)332.4 (± 222.1)476.8 (± 305.3)P < 0.01 (mean ± SD)
2 (9)
3 (25)
1Fattovich et al[21]226ELISA (Quantikine, R and D systems, Minneapolis, MN, United States )1 (92)2.47 ± 0.232.65 ± 0.28P < 0.001 (log mean ± SD)2092712
2 (87)2.37 ± 0.312.33 ± 0.35P > 0.05 (log mean ± SD)
3 (47)2.42 ± 0.212.67 ± 0.46P < 0.05a (log mean ± SD)
Kurelac et al[33]46ELISA (Quantikine, R and D systems, Minneapolis, MN, United States )1 (46)185 (63-518)395.5 (111-926)P < 0.0001 (median, range)2620
Darling et al[31]272ELISA (Quantikine, R and D systems, Minneapolis, MN, United States )1 (272)437 (± 31)704 (± 44)P < 0.001 (mean ± SD)157115
Derbala et al[32]159Luminex, Cytokine multiplex immunoassay kit (Merck Millipore, Billerica, MA, United States)4 (159)Exact data not provided, only graphic presentationP < 0.001 (median, IQR)9861
Al-Ashgar et al[19]64ELISA (Quantikine, R andD systems, Minneapolis, MN, United States )4 (64)462 (± 282.6)840.4 (± 490.6)P < 0.01 (mean ± SD)4123